TARSUS PHARMACEUTICALS, INC.: cashflow_financing
| Value | {"amount": 154656000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2024-01-01 – 2024-12-31 |
| Status | current |
| Entity | TARSUS PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:18:26.464024+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/da5a553d-4cd9-437d-8942-c85a9038fa7a
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001819790-25-000011Retrieved: 2026-08-19T18:18:26.464024+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001819790/cashflow-financing/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/da5a553d-4cd9-437d-8942-c85a9038fa7a
History
- no predecessors — first report